Skip to content
Disclosery

Privium Fund Management B.V.

Follow

13F filer, CIK 1795097, AMSTERDAM, Netherlands

Privium Fund Management B.V. reported $463,503,750 across 55 holdings for the quarter ended 2025-06-30, in a 13F-HR filed 2025-07-30. Its ten largest share positions make up 81.5% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001754960-25-000506

Period
2025-06-30
Reported value
$464M
Holdings
55
Top 10 weight
81.5%
New
7
Sold out
8

Largest buys vs the previous quarter

SecurityShares changeApprox. value
COINnew+70,000$24.2M
TSLAadded+22,000$6.79M
BIIBnew+20,500$2.67M
AMZNadded+8,000$1.76M
SHOPadded+15,000$1.71M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
SPOTreduced-31,000-$23.1M
SNOWexited-48,000-$7.13M
NETexited-60,000-$6.76M
SPRINGWORKS THERAPEUTICS INCexited-123,980-$5.47M
QUREreduced-131,653-$1.84M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q2 2025

Share positions as resolved from 13F-HR 0001754960-25-000506, largest first. % of portfolio is the value over $463,503,750, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
SPOTSPOTIFY TECHNOLOGY S AQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 149,000 shares; 2024Q4: 145,000 shares; 2025Q1: 145,000 shares; 2025Q2: 114,000 shares 114,000$84.8M18.3%-31,000Timeline
TSLATESLA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 216,000 shares; 2024Q4: 220,000 shares; 2025Q1: 220,000 shares; 2025Q2: 242,000 shares 242,000$74.7M16.11%+22,000Timeline
SHOPSHOPIFY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 415,000 shares; 2024Q4: 415,000 shares; 2025Q1: 415,000 shares; 2025Q2: 430,000 shares 430,000$49M10.57%+15,000Timeline
PLTRPALANTIR TECHNOLOGIES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 475,000 shares; 2024Q4: 370,000 shares; 2025Q1: 360,000 shares; 2025Q2: 350,000 shares 350,000$46.6M10.05%-10,000Timeline
AMZNAMAZON COM INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 141,000 shares; 2024Q4: 141,000 shares; 2025Q1: 141,000 shares; 2025Q2: 149,000 shares 149,000$32.8M7.07%+8,000Timeline
SESEA LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 210,000 shares; 2024Q4: 210,000 shares; 2025Q1: 210,000 shares; 2025Q2: 210,000 shares 210,000$32.5M7.01%0Timeline
COINCOINBASE GLOBAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 70,000 shares 70,000$24.2M5.22%newTimeline
NVDANVIDIA CORPORATIONQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 73,000 shares; 2024Q4: 73,000 shares; 2025Q1: 73,000 shares; 2025Q2: 81,000 shares 81,000$12.5M2.7%+8,000Timeline
IONSIONIS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 250,744 shares; 2024Q4: 266,794 shares; 2025Q1: 267,594 shares; 2025Q2: 267,594 shares 267,594$10.7M2.31%0Timeline
PRQRPROQR THRAPEUTICS N VQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 5,632,388 shares; 2024Q4: 4,985,633 shares; 2025Q1: 4,985,633 shares; 2025Q2: 4,997,562 shares 4,997,562$10M2.17%+11,929Timeline
ARWRARROWHEAD PHARMACEUTICALS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 333,356 shares; 2024Q4: 380,586 shares; 2025Q1: 629,214 shares; 2025Q2: 612,214 shares 612,214$9.85M2.13%-17,000Timeline
RAREULTRAGENYX PHARMACEUTICAL INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 242,512 shares; 2024Q4: 258,380 shares; 2025Q1: 249,804 shares; 2025Q2: 253,304 shares 253,304$9.18M1.98%+3,500Timeline
QUREUNIQURE NVQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 744,916 shares; 2024Q4: 742,162 shares; 2025Q1: 579,139 shares; 2025Q2: 447,486 shares 447,486$6.26M1.35%-131,653Timeline
AXSMAXSOME THERAPEUTICS INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 80,232 shares; 2024Q4: 62,232 shares; 2025Q1: 52,732 shares; 2025Q2: 52,732 shares 52,732$5.43M1.17%0Timeline
MRKMERCK & CO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 60,111 shares; 2024Q4: 72,611 shares; 2025Q1: 41,093 shares; 2025Q2: 59,093 shares 59,093$4.83M1.04%+18,000Timeline
ARQTARCUTIS BIOTHERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 325,709 shares; 2025Q1: 325,709 shares; 2025Q2: 344,472 shares 344,472$4.74M1.02%+18,763Timeline
ZLABZAI LAB LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 215,624 shares; 2024Q4: 185,062 shares; 2025Q1: 132,189 shares; 2025Q2: 132,189 shares 132,189$4.65M1%0Timeline
VRTXVERTEX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 8,300 shares; 2025Q2: 8,300 shares 8,300$3.75M0.81%0Timeline
ACADACADIA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 148,400 shares; 2024Q4: 148,400 shares; 2025Q1: 148,400 shares; 2025Q2: 148,400 shares 148,400$3.17M0.68%0Timeline
MRNAMODERNA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 40,482 shares; 2024Q4: 82,476 shares; 2025Q1: 75,576 shares; 2025Q2: 103,433 shares 103,433$2.97M0.64%+27,857Timeline
BIIBBIOGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 20,500 shares 20,500$2.67M0.58%newTimeline
CRSPCRISPR THERAPEUTICS AGQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 30,347 shares; 2024Q4: 34,997 shares; 2025Q1: 60,097 shares; 2025Q2: 44,700 shares 44,700$2.17M0.47%-15,397Timeline
ABEVAMBEV SAQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 622,314 shares; 2024Q4: 652,357 shares; 2025Q1: 804,206 shares; 2025Q2: 795,786 shares 795,786$1.93M0.42%-8,420Timeline
CVNACARVANA COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 5,000 shares 5,000$1.68M0.36%newTimeline
URGNUROGEN PHARMA LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 27,691 shares; 2025Q1: 107,622 shares; 2025Q2: 107,622 shares 107,622$1.4M0.3%0Timeline
ROIVROIVANT SCIENCES LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 484,500 shares; 2024Q4: 215,506 shares; 2025Q1: 126,923 shares; 2025Q2: 126,923 shares 126,923$1.39M0.3%0Timeline
RNAMAVIDITY BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 25,600 shares; 2024Q4: 31,900 shares; 2025Q1: 34,500 shares; 2025Q2: 46,000 shares 46,000$1.31M0.28%+11,500Timeline
KRYSKRYSTAL BIOTECH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 6,350 shares; 2024Q4: 9,250 shares; 2025Q1: 7,510 shares; 2025Q2: 9,320 shares 9,320$1.3M0.28%+1,810Timeline
BNTXBIONTECH SEQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 10,987 shares 10,987$1.18M0.25%newTimeline
RCKTROCKET PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 294,800 shares; 2024Q4: 397,650 shares; 2025Q1: 432,760 shares; 2025Q2: 432,760 shares 432,760$1.12M0.24%0Timeline
HIMSHIMS & HERS HEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 22,000 shares 22,000$1.1M0.24%newTimeline
MGTXMEIRAGTX HLDGS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 213,960 shares; 2024Q4: 225,078 shares; 2025Q1: 117,000 shares; 2025Q2: 163,000 shares 163,000$1.06M0.23%+46,000Timeline
PFEPFIZER INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 21,978 shares; 2024Q4: 21,978 shares; 2025Q1: 32,327 shares; 2025Q2: 37,029 shares 37,029$927K0.2%+4,702Timeline
WVEWAVE LIFE SCIENCES LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 48,834 shares; 2024Q4: 88,000 shares; 2025Q1: 113,550 shares; 2025Q2: 135,550 shares 135,550$884K0.19%+22,000Timeline
PAASPAN AMERN SILVER CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 26,484 shares; 2024Q4: 21,284 shares; 2025Q1: 21,284 shares; 2025Q2: 29,747 shares 29,747$845K0.18%+8,463Timeline
NOVNOV INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 37,925 shares; 2024Q4: 42,889 shares; 2025Q1: 49,745 shares; 2025Q2: 63,876 shares 63,876$825K0.18%+14,131Timeline
FDMT4D MOLECULAR THERAPEUTICS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 98,500 shares; 2024Q4: 121,000 shares; 2025Q1: 131,000 shares; 2025Q2: 197,458 shares 197,458$819K0.18%+66,458Timeline
URNMSPROTT FDS TRQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 8,856 shares; 2024Q4: 10,276 shares; 2025Q1: 12,114 shares; 2025Q2: 16,278 shares 16,278$761K0.16%+4,164Timeline
LXEOLEXEO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 138,115 shares; 2025Q1: 160,198 shares; 2025Q2: 178,356 shares 178,356$753K0.16%+18,158Timeline
VZLAVIZSLA SILVER CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 116,521 shares; 2024Q4: 116,521 shares; 2025Q1: 192,487 shares; 2025Q2: 250,790 shares 250,790$732K0.16%+58,303Timeline
SRPTSAREPTA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 39,400 shares 39,400$698K0.15%newTimeline
AUTLAUTOLUS THERAPEUTICS LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 185,639 shares; 2024Q4: 231,674 shares; 2025Q1: 251,674 shares; 2025Q2: 294,142 shares 294,142$674K0.15%+42,468Timeline
SASEABRIDGE GOLD INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 32,087 shares; 2024Q4: 35,987 shares; 2025Q1: 44,074 shares; 2025Q2: 44,074 shares 44,074$648K0.14%0Timeline
RXRXRECURSION PHARMACEUTICALS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 78,000 shares; 2024Q4: 119,000 shares; 2025Q1: 119,000 shares; 2025Q2: 119,000 shares 119,000$610K0.13%0Timeline
VALVALARIS LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 7,611 shares; 2024Q4: 14,182 shares; 2025Q1: 20,222 shares; 2025Q2: 13,803 shares 13,803$606K0.13%-6,419Timeline
EMX RTY CORPEMX RTY CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 216,968 shares; 2025Q1: 216,968 shares; 2025Q2: 216,968 shares 216,968$545K0.12%0
SDSANDRIDGE ENERGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 23,300 shares; 2024Q4: 23,300 shares; 2025Q1: 23,300 shares; 2025Q2: 37,022 shares 37,022$401K0.09%+13,722Timeline
NENOBLE CORP PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 10,525 shares; 2024Q4: 10,525 shares; 2025Q1: 14,287 shares; 2025Q2: 14,287 shares 14,287$392K0.08%0Timeline
TSHATAYSHA GENE THERAPIES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 120,000 shares; 2024Q4: 134,900 shares; 2025Q1: 134,900 shares; 2025Q2: 134,900 shares 134,900$316K0.07%0Timeline
TDWTIDEWATER INC NEWQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 5,350 shares 5,350$255K0.06%newTimeline
SBSWSIBANYE STILLWATER LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 34,040 shares; 2024Q4: 34,040 shares; 2025Q1: 34,040 shares; 2025Q2: 34,040 shares 34,040$248K0.05%0Timeline
DYNDYNE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 15,016 shares; 2024Q4: 20,366 shares; 2025Q1: 27,566 shares; 2025Q2: 27,566 shares 27,566$239K0.05%0Timeline
ALXOALX ONCOLOGY HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 509,059 shares; 2024Q4: 509,059 shares; 2025Q1: 509,059 shares; 2025Q2: 509,059 shares 509,059$221K0.05%0Timeline
FATEFATE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 50,000 shares; 2024Q4: 87,000 shares; 2025Q1: 109,026 shares; 2025Q2: 111,090 shares 111,090$127K0.03%+2,064Timeline
VYGRVOYAGER THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 21,645 shares; 2025Q2: 25,241 shares 25,241$78.8K0.02%+3,596Timeline

Sold out in Q2 2025

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
SNOWSNOWFLAKE INC48,000$7.13Mshares
NETCLOUDFLARE INC60,000$6.76Mshares
SPRINGWORKS THERAPEUTICS INCSPRINGWORKS THERAPEUTICS INC123,980$5.47Mshares
CPNGCOUPANG INC81,900$1.83Mshares
ALNYALNYLAM PHARMACEUTICALS INC5,716$1.54Mshares
IMVTIMMUNOVANT INC72,000$1.23Mshares
AIGAMERICAN INTL GROUP INC6,483$564Kshares
NTLAINTELLIA THERAPEUTICS INC58,709$417Kshares

How Q2 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001754960-25-000506 base2025-07-30acceptance time not in the bulk data set